GALECTIN THERAPEUTICS INC (GALT) Insider Trading & SEC Filings
Last SEC filing
GALECTIN THERAPEUTICS INC (GALT) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-16. Insider sales over the same period: 8 transactions worth $522K. 2 Form 8-K material event filings were reported by GALT in the last 90 days. 4 Form 144 notices of proposed sale were filed for GALT stock. InsiderAlpha tracks every GALT SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About GALECTIN THERAPEUTICS INC (GALT)
GALECTIN THERAPEUTICS INC trades under the ticker GALT. InsiderAlpha tracks 60 primary SEC Form 4 filings from 15 reporting insiders for GALT since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001133416 |
90-Day SEC Filing Activity
| Insider sales (90d) | 8 ($522K) |
|---|---|
| Form 4 filings (90d) | 5 |
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-07-16 |
Recent GALT Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Khurram Jamil | Chief Medical Officer | S - Open-market sale [10b5-1] | 16.2K | $5.13 | $83K | SEC | |
| Khurram Jamil | Chief Medical Officer | M - Option exercise [10b5-1] | 16.2K | $3.04 | $49K | SEC | |
| Khurram Jamil | Chief Medical Officer | S - Open-market sale [10b5-1] | 47.5K | $5.04 | $239K | SEC | |
| Harold H. Shlevin | Insider | M - Option exercise [10b5-1] | 22.3K | $1.23 | $27K | SEC | |
| Harold H. Shlevin | Insider | S - Open-market sale [10b5-1] | 22.3K | $5.04 | $112K | SEC | |
| Khurram Jamil | Chief Medical Officer | M - Option exercise [10b5-1] | 47.5K | $2.50 | $119K | SEC | |
| Harold H. Shlevin | Insider | M - Option exercise [10b5-1] | 7.7K | $1.23 | $10K | SEC | |
| Harold H. Shlevin | Insider | S - Open-market sale [10b5-1] | 7.7K | $5.00 | $39K | SEC | |
| Khurram Jamil | Chief Medical Officer | S - Open-market sale [10b5-1] | 2.5K | $5.00 | $13K | SEC | |
| Khurram Jamil | Chief Medical Officer | S - Open-market sale [10b5-1] | 2.0K | $5.00 | $10K | SEC | |
| Khurram Jamil | Chief Medical Officer | M - Option exercise [10b5-1] | 2.5K | $2.50 | $6K | SEC | |
| Khurram Jamil | Chief Medical Officer | M - Option exercise [10b5-1] | 2.0K | $2.20 | $4K | SEC | |
| Khurram Jamil | Chief Medical Officer | S - Open-market sale [10b5-1] | 7.6K | $3.14 | $24K | SEC | |
| Khurram Jamil | Chief Medical Officer | M - Option exercise [10b5-1] | 7.6K | $1.23 | $9K | SEC | |
| Khurram Jamil | Chief Medical Officer | M - Option exercise [10b5-1] | 568 | $1.23 | $699 | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for GALECTIN THERAPEUTICS INC (GALT). Updated in real time as new filings are submitted to the SEC.
Most-Active GALT Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Khurram Jamil | 18 | $560K |
| Harold H. Shlevin | 6 | $188K |
Recent GALT Form 8-K Material Events
- - Item 7.01, 9.01 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 2.02, 9.01 · Earnings · neutral [SEC]
Galectin Therapeutics issued a press release on March 31, 2026 announcing its financial results for the year ended December 31, 2025, along with a business update. The filing provides results of operations and financial condition without indicating whether results beat or missed - - Item 5.02, 9.01 · Leadership · positive [SEC]
Galectin Therapeutics appointed Dr. Henry Brem, an internationally recognized neurosurgeon-scientist and professor at Johns Hopkins University, to its Board of Directors effective March 12, 2026. Dr. Brem brings significant expertise in translational medicine, surgical oncology,
Recent GALT Form 144 Notices of Proposed Sale
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
Recent Insider Filings
- - Khurram Jamil (Chief Medical Officer)
- - Harold H. Shlevin (Insider)
- - Khurram Jamil (Chief Medical Officer)
- - Khurram Jamil (Chief Medical Officer)
- - Khurram Jamil (Chief Medical Officer)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in GALT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
GALT Insider Trading - FAQ
- What is the latest insider trade for GALT?
- GALECTIN THERAPEUTICS INC (GALT) had 5 insider filings in the last 90 days, with the most recent on 2026-07-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying GALT stock?
- 0 insider purchases of GALT were filed in the last 90 days.
- How many insiders are selling GALT stock?
- 8 insider sales of GALT were filed in the last 90 days, totaling $522K.
- Where can I see GALT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks GALT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $GNPX Genprex, Inc.
- $GOVX GeoVax Labs, Inc.
- $GRI GRI Bio, Inc.
- $GRML Greenland Mines Ltd
- $GTBP GT Biopharma, Inc.
- $HYEX HEALTHY EXTRACTS INC.
- $ICU SeaStar Medical Holding Corp
- $IMA ImageneBio, Inc.
- $IVF INVO Fertility, Inc.
- $JAGX Jaguar Health, Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live GALT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.